British Journal of Clinical Pharmacology· 2019Q1
The Medication Adherence Report Scale: A measurement tool for eliciting patients' reports of nonadherence
- 520citations
- Q1SCImago
- 2019year
Short summary
The 5-item Medication Adherence Report Scale (MARS-5) demonstrates acceptable reliability and validity for measuring patient self-reported medication adherence across hypertension, asthma, and diabetes.
AI-generated from the title and abstract; the full text is not read.
Key points
- The MARS-5 is a 5-item self-report tool for measuring medication adherence.
- The scale demonstrated acceptable internal reliability (Cronbach's α 0.67-0.89) and test-retest reliability (Pearson's r = 0.97).
- Criterion-related validity was shown by linking higher adherence to better blood pressure control in hypertensive patients.
- Construct validity was supported by associations between adherence and patients' beliefs about medication necessity and concerns.
AI-generated from the title and abstract; the full text is not read.
Abstract
Aims This study aimed to establish the psychometric properties of a questionnaire measure of patients' adherence to medications to elicit patients' report of medication use in a variety of clinical samples. The reliability and validity were assessed in patients with hypertension. Additional analyses were performed on other patient groups. Methods Using a cross‐sectional study design, a 10‐item version of the Medication Adherence Report Scale (©Professor Rob Horne) was piloted in two samples of patients receiving treatment for hypertension (n = 50 + 178), asthma (n = 100) or diabetes (n = 100) at hospital outpatient or community clinics in London and the south‐east of England. Following principal components analysis, five items were retained to form MARS‐5 (©Professor Rob Horne). Evaluation comprised internal reliability, test‐retest reliability, criterion‐related validity (relationship with blood pressure control) and construct validity (relationship with patients' beliefs about medicines). Results The MARS‐5 demonstrated acceptable reliability (internal and test‐retest) and validity (criterion‐related and construct validity) in these patient groups. Internal reliability (Cronbach's α) ranged from 0.67 to 0.89 across all patient groups; test‐retest reliability (Pearson's r ) was 0.97 in hypertension. Criterion‐related validity was established with more adherent hypertension patients showing better blood‐pressure control (χ 2 = 4.24, df = 1, P < .05). Construct validity with beliefs about medicines was demonstrated with higher adherence associated with stronger beliefs in treatment necessity and lower treatment concerns. Conclusions The MARS‐5 performed well on several psychometric indicators in this study. It shows promise as an effective self‐report tool for measuring patients' reports of their medication use across a range of health conditions.
The authors' abstract, as published at the source. British Journal of Clinical Pharmacology, 2019 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Family Practice
Family PracticeMedicine